<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3993628&amp;fmt=gif">
Skip to the main content.

Neural Connections Blog

MD Biosciences insights discussing preclinical research in Pain and Neurodegenerative Conditions

translational research (2)

Inflammatory Biomarker Detection Increases Value in Early Drug Development

Inflammation is a key pathological driver in many neurological diseases. The interplay between the central and peripheral nervous systems and the...

Read More
chemotherapy-induced neuropathy

Preclinical Efficacy Models of Chemotherapy-Induced Peripheral Neuropathy

Chemotherapeutics agents are commonly used to treat cancer, but come with side effects such as neurotoxicity and peripheral neuropathy, which...

Read More

Promoting Diversity for Translational Success

In preclinical efficacy studies, several factors are often overlooked, and it is important to evaluate variables like sex, age, species,...

Read More

The HTX-011 Story

HTX-011 Breakthrough in Pain Management ZYNRELEF, the commercial name for HTX-011, is the first and only FDA-approved extended-release dual-acting...

Read More

Wound Healing Models in Pigs

It is important to bridge the gap between lab findings and clinical applications using translational models, ensuring effective translation for human...

Read More

Advancing Nerve Injury and Repair Models

Understanding Mechanisms Underlying Neuropathic Pain

Read More
3 ways to approach translational research in pain, CNS, and neurodegeneration

Three ways to approach translation

As the general population continues to age, the economic burden of chronic pain and neurodegenerative diseases is increasing and becoming...

Read More
translational research facility

The effect of the housing environment and handling on behavior assays

An excerpt from MD Biosciences publication in the Autumn 2022 issue of Göttingen Minipigs Magazine. MD Biosciences operates a neuroscience research...

Read More